approached significanceP = .06
The decrease in triglycerides from baseline in the vitamin D group approached significance ( P = .06), whereas levels remained stable in the placebo group ( P = .62).
The decrease in triglycerides from baseline in the vitamin D group approached significance ( P = .06), whereas levels remained stable in the placebo group ( P = .62).
In the placebo group, there were no changes in these parameters but the decrease in BMC from baseline was almost significant ( P = .07).